Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes.
使用 1.0 Mg 週劑量 Semaglutide 治療的 2 型糖尿病患者在現實世界中的 HbA1c 變化。
J Health Econ Outcomes Res 2024-11-07
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review.
糖尿病患者中一周一次 semaglutide 的真實世界臨床效果:系統文獻回顧。
Expert Rev Clin Pharmacol 2023-02-15
Once-weekly semaglutide use in patients with type 2 diabetes: Real-world data from the SURE Italy observational study.
糖尿病患者使用每週一次的semaglutide:來自SURE Italy觀察性研究的實際數據。
Diabetes Obes Metab 2023-05-13
Real-world impact of once-weekly subcutaneous semaglutide after 2 years of follow-up: Results from a nationwide observational study in people with type 2 diabetes.
經過2年追蹤後,一周一次皮下注射semaglutide對2型糖尿病患者的真實世界影響:來自全國性觀察性研究的結果。
Diabetes Obes Metab 2023-05-13
Real-World Hemoglobin A1c Changes, Prescribing Provider Types, and Medication Dose Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide.
Type 2 糖尿病患者在口服 Semaglutide 初始治療時的真實世界糖化血紅蛋白變化、處方醫師類型和藥物劑量。
Adv Ther 2023-12-06
Real-world glycated haemoglobin changes among type 2 diabetes mellitus patients treated with a maintenance dose of 7 mg or 14 mg of oral semaglutide.
接受維持劑量為7毫克或14毫克口服semaglutide治療的2型糖尿病患者之真實世界糖化血紅蛋白變化。
Diabetes Obes Metab 2024-05-08
Real-world HbA<sub>1c</sub> changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes.
開始使用一周一次的semaglutide治療糖尿病的2型糖尿病患者的實際HbA<sub>1c</sub>變化和處方特徵。
J Diabetes Metab Disord 2024-06-27
Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice.
接受皮下注射 semaglutide 治療的第二型糖尿病患者,在真實世界臨床實踐中體重和體組成、代謝參數以及生活品質的變化。
Front Endocrinol (Lausanne) 2024-07-17
Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study).
西班牙 2 型糖尿病患者每週一次皮下注射 Semaglutide 的實際評估(SEMA-RW 研究)。
Nutrients 2024-08-10
Oral Semaglutide in Type 2 Diabetes: Clinical-Metabolic Outcomes and Quality of Life in Real-World Practice.
口服 Semaglutide 在 2 型糖尿病中的臨床-代謝結果及現實世界實踐中的生活品質。
J Clin Med 2024-08-29
REAL life study of subcutaneous SEMaglutide in patients with type 2 diabetes in SPain: Ambispective, multicenter clinical study. Results in the GLP1-experienced cohort.
西班牙2型糖尿病患者皮下SEMaglutide的實際生活研究:前瞻性與回顧性相結合的多中心臨床研究。GLP1經驗組的結果。
J Diabetes Complications 2024-10-23